We’ve talked extensively on this podcast about how COVID ushered in a period of rapid adoption of telemedicine. According to McKinsey, we went from around 11% of people using telehealth to around 46% during the pandemic.

Few companies in the world were better poised to capitalize on this moment than Amwell. What’s so interesting about Amwell is that they weren’t created to meet this moment. They have been patiently and persistently ringing the telemedicine bell since 2006. Back then, seeing your doctor over your computer seemed like a pipe dream, or worse, some dystopian future.

Now, well, things look a bit different. Building the infrastructure to deliver healthcare virtually is an idea whose time has come. And Amwell’s persistence has made them a world leader in the market.

Now, Amwell is expanding the definition of virtual care. Last year they acquired StartUp Health portfolio company Conversa Health, which uses chatbot functionality to automate care in between visits to improve efficiency and outcomes.

This episode of the podcast is pulled from a Fireside Chat where we sat down with Roy Schoenberg, MD, CEO and Co-founder of Amwell, and Murray Brozinsky, CEO of Conversa Health. The chat, which was moderated by Steven Krein, CEO and Co-founder of StartUp Health, pulls back the curtain on how these two companies came together, the lessons learned from the process, and what it all means for the future of virtual care. Roy and Murray are a wealth of wisdom and experience when it comes to digital health, so it was a powerful conversation. Hope you enjoy.

Investors: How to invest in StartUp Health Moonshots healthmoonshots.com
Want more content like this? You can subscribe to the podcast as well as other health innovation updates at startuphealth.com/content.
Sign up for StartUp Health Insider™ to get funding insights, news, and special updates delivered to your inbox.